Dan Roden

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

L-r: Eric Johnson, Björn Knollmann, Dai Chung, Dan Roden, Russell Rothman, Susan Wente, Carrie Kitko, Dane Chetkovich, Rangaraj Ramanujam, Timothy Vogus, Berk Sensoy and Jeff Balser. (John Russell/Vanderbilt)

Nine new endowed chair recipients honored

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

Personalized drug prescribing program expands, upgrades

Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.

Vanderbilt researchers’ papers among those most cited

Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers.

McGill University honors Roden’s research career

Dan Roden, M.D., Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center (VUMC), was named to receive the 2017 Medicine Alumni Global Lifetime Achievement Award by the Faculty of Medicine of his alma mater, McGill University.

Vanderbilt University Medical Center (Vanderbilt University)

VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.

1 2 3 4 5